Voluntary recall of Apo-Warfarin 1mg tablet (Batch no: JL4994)

Pharmaforte updates healthcare professionals on the recent recall of their Apo-Warfarin 1mg tablet (Batch No: JL4994) due to deviation in the product's quality specifications. The INR of patients taking this affected batch of Apo-Warfarin may be affected by this deviation in the product's quality specifications. Prescribers whose patients that have been prescribed Apo-Warfarin 1mg (Batch No: JL4994) are advised to initiate additional monitoring processes. Additionally, prescribers are also advised to monitor their patients closely if patients on the affected batch are substituted with a new unaffected batch of warfarin.
Healthcare professional, Therapeutic Products
Published:

Dear Healthcare Professional Letters

12 Dec 2019

Only abstracts of the Dear Healthcare Professional Letters (DHCPL) are provided on this website. Details of the letters can be found on the MOH Alert System, which is accessible via the Health Professionals Portal (HPP), a one-stop portal for all healthcare professionals in Singapore. Dentists, medical doctors and pharmacists may access HPP at https://www.hpp.moh.gov.sg and follow the procedures below to access the MOH Alert system.

Step 1: Select your profession under 'For Healthcare Professionals’.

Step 2: Click on 'Restricted Content' and log in via SingPass.

Step 3: Click on the MOH Alert icon under ‘Applications’.

Step 4: Click on the Drug Alert tab to view the DHCPLs.